22.7 C
Vientiane
Monday, May 12, 2025
spot_img
Home Blog Page 782

Dun & Bradstreet in Hong Kong Announces Strategic Relocation to Better Serve Clients

HONG KONG, Jan. 27, 2025 /PRNewswire/ — Dun & Bradstreet (D&B), a leading global provider of business decisioning data and analytics, announced its official office relocation in Hong Kong SAR (HK) to Six Pacific Place, Wan Chai. The strategic move will enable Dun & Bradstreet in Hong Kong (D&B in HK) to accelerate its growth agenda, streamline its operations and better serve its clients in the heart of this vibrant city.

The new facility, situated at the heart of HK’s bustling business district with state-of-the-art facilities and quality space, will serve as a key hub, enabling D&B in HK to collaborate with partners and clients more effectively.

“We are thrilled to announce our move to this new facility,” said Andrew Wu, General Manager of D&B China. “This move represents our continued investment in HK and underscores our dedication to the HK market. By combining global data and local expertise, we aim to provide unparalleled services to our clients in the international market and make informed decisions that drive growth and success.”

D&B’s history in HK is longstanding since 1981, with a strategic presence to enhance HK’s position as a leading financial center. As the sole operator of the Commercial Credit Reference Agency (CCRA) in HK since 2004, appointed by the Hong Kong Association of Banks and the Hong Kong Association of Restricted License Banks and Deposit Taking Companies, D&B in HK has played a pivotal role in providing analytics and risk management solutions to empower financial institutions with decision-ready insights. Additionally, the company has contributed to the growth of cross-boundary financing by providing cross-boundary credit solutions that empower businesses operating in the Greater Bay Area (GBA) to effectively access the credit and financing they require.

Over the years, D&B also actively supported HK’s position as a global trade hub. D&B’s partnership with Hong Kong Trade Development Council (HKTDC) and the Hong Kong Export Credit Insurance Corporation (HKECIC) has further supported SMEs and exporters in HK to navigate the complexities of international trade. Last year D&B launched a digital tool “D&B Risk Analytics – Compliance Intelligence” to further contribute to the development of HK’s trade ecosystem, allowing companies to automate and perform ongoing KYC (Know-Your-Customer) and KYB (Know-Your-Business) due diligence, empowering enterprises to better highlight material risk and greatly reduce workloads while improving the intelligence of risk decisions.

D&B has continually evolved, driving innovation for businesses across the region with a suite of innovative products and services. Recently, the company launched ChatD&B, a new Generative AI assistant that provides instant business insights using the power of D&B global data cloud to deliver reliable business data and actionable insights within seconds. This tool exemplifies D&B’s commitment to preserving digital trust, reliable data-driven decision-making, and the sustainability of data ecosystems.

As D&B embarks on this new chapter in HK, the company reaffirms its dedication to the market and its commitment to delivering world-class data and analytics solutions to support HK as a Financial and Trade Hub.

More information about D&B in HK’s new address and services can be found at https://www.dnb.com.hk/.

About Dun & Bradstreet

Dun & Bradstreet, a leading global provider of business decisioning data and analytics, enables companies around the world to improve their business performance. Dun & Bradstreet’s Data Cloud fuels solutions and delivers insights that empower customers to accelerate revenue, lower cost, mitigate risk, and transform their businesses. Since 1841, companies of every size have relied on Dun & Bradstreet to help them manage risk and reveal opportunity. We combine global data with local insights to help our clients to make smarter decisions. For more information on Dun & Bradstreet, please visit www.dnb.com.hk.

Colombian President Celebrates Landmark PV Project Exclusively Powered by JA Solar

BEIJING, Jan. 27, 2025 /PRNewswire/ — Recently, Colombian President Gustavo Petro attended a ceremony at a refinery near Cartagena, where he personally signed a JA Solar module to commemorate the successful completion of a groundbreaking PV project. This marks the first PV power plant built at an oil refinery across Latin America, a signature initiative supporting President Petro’s renewable energy development agenda.

JA Solar exclusively supplied the PV modules for this 23MW project, constructed by PowerChina. The installation, located at the Cartagena Refinery of Colombian Petroleum Company (Ecopetrol), stands as a pioneering example of integrating renewable energy into traditional industrial settings. Ecopetrol’s CEO, Ricardo Roa, hailed the project as “a milestone in replacing conventional oil and gas with clean energy solutions.”

At the inauguration, President Petro praised the project’s role in reshaping Colombia’s energy landscape. Calling it a “milestone with far-reaching implications,” he expressed hope for expanding similar initiatives nationwide. Petro also extended his gratitude to JA Solar and other Chinese enterprises for introducing advanced technology and high-quality products to Colombia, fostering a collaborative approach to energy transition.

The completion of this landmark project underscores JA Solar’s unwavering dedication to advancing renewable energy across Latin America. The company has achieved significant milestones in several key markets in this region.

In 2023, JA Solar partnered with Solatio, one of Brazil’s largest PV developers, to supply 1.2GW of modules for the Cassiolândia and Paranaíba PV Power Stations in Mato Grosso do Sul, contributing to over 4GW across seven Solatio projects. In Chile, JA Solar exclusively powered the 480MW CEME1 PV Power Station, the country’s largest single-unit PV project, operational since 2024 and accounting for 10% of Chile’s renewable energy capacity.

In 2024, EUPD Research awarded JA Solar the titles of “Top Brand PV Latin America” and “Top Brand PV” in Brazil, Chile, Colombia, and Mexico, highlighting the company’s growing market leadership and customer trust. “Building on this success, JA Solar remains fully committed to driving Latin America’s renewable energy transition through technological innovation and market excellence,” said Aiqing Yang, Executive President of JA Solar. “By leveraging our industry-leading products and expertise, we aim to continue playing a pivotal role in advancing global carbon neutrality and fostering a sustainable future.”

Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG, Jan. 27, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the treatment of moderate to severe plaque psoriasis. The strategic combination of drugs such as gumokimab and ebronucimab (PCSK9) to address the differentiated treatment needs of psoriasis has further enhanced the company’s overall product synergy in the autoimmune disease field.

Gumokimab is the eighth successfully approved drug developed independently by Akeso (with six already approved for market), and it is also the third non-oncology innovative drug, following ebronucimab (PCSK9) and ebdarokimab (IL-12/IL-23), to progress to the commercialization stage.

Gumokimab has been evaluated in four clinical studies involving patients with moderate to severe plaque psoriasis, including one pivotal Phase III clinical trial (AK111-301) and three supportive studies.

Efficacy data show that gumokimab acts quickly, with significant therapeutic improvement observed after just 2 weeks of treatment.

Short-term Efficacy: At week 12, the PASI 75 response rate approached 96%, with an sPGA 0/1 response rate nearing 90%. The PASI 90 response rate was close to 80%, and the PASI 100 response rate exceeded 40%, all efficacy measures significantly superior to the placebo group. Over 80% of patients achieved a PASI 90 response, and approximately 50% achieved a PASI 100 response.

Long-term Efficacy: Gumokimab monotherapy demonstrated sustained efficacy over 52 weeks, with continuous improvement and long-lasting maintenance. By week 52, the PASI 75 response rate approached 100%, with stable sPGA 0/1 response rates. The PASI 90 and PASI 100 response rates further improved to nearly 90% and 65%, respectively.

Safety: During both the placebo-controlled phase and the overall treatment phase, the incidence of adverse events was comparable between the gumokimab and placebo groups, with the gumokimab group showing slightly lower values across all metrics.

Professor Xu Jinhua, the principal investigator of the pivotal registration study of gumokimab, professor at Huashan Hospital, Fudan University, stated: “There is an increasing demand for medications that offer rapid onset, short-term efficacy, long-term stability, and good tolerability. Gumokimab, an IL-17A IgG1 monoclonal antibody, directly targets the IL-17RA pathway, a key driver of psoriasis, providing faster and more effective results. Data from four studies demonstrate its potential to better meet patient needs, particularly in achieving near-clearance of lesions and maintaining disease stability. Moreover, the incidence of adverse events with gumokimab is comparable to that of the placebo, indicating good safety and tolerability. We eagerly anticipate the early availability of Gumokimab as a more efficient treatment option for psoriasis patients in China.”

Dr. Yu Xia, Founder, Chairwoman, and CEO of Akeso, stated: “We are excited about the outstanding results of gumokimab in clinical trials and the successful submission of its new drug application for market approval. I would like to express my sincere gratitude to all the participants in the project and to all the patients who took part in the clinical trials for their hard work and trust.

Psoriasis patients are in urgent need of better treatment options, and Akeso is addressing this with ebdarokimab and gumokimab, which target different disease pathways and complement each other in treatment, allowing us to meet a wide range of patient needs.

With the successful launch of products such as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23) and gumokimab (IL-17), as well as the efficient advancement of innovative non-oncology drugs targeting multiple indications, including manfidokimab (IL-4R), IL-4R/ST2 bispecific antibody, and therapies for neurodegenerative diseases, the vitality and synergy of our product portfolio are growing stronger. This progress significantly enhances Akeso’s global competitiveness in the non-oncology business segment. At the same time, with the development and optimization of a more systematic, refined, and efficient commercialization team, we have formulated a comprehensive and scientific commercialization strategy for our non-oncology products. This strategy is designed to accelerate market expansion, positioning our non-oncology business as a powerful driver of the company’s high-quality growth.”

About gumokimab

Gumokimab is an innovative, humanized IL-17 (interleukin-17) monoclonal antibody developed by Akeso for the treatment of autoimmune diseases such as psoriasis and ankylosing spondylitis. IL-17 is a pro-inflammatory cytokine primarily secreted by activated Th17 cells, which binds to its receptor (IL-17R) on cell surfaces, mediating immune-inflammatory responses and playing a critical role in the pathogenesis of psoriasis and ankylosing spondylitis. Gumokimab specifically targets IL-17, blocking the IL-17/IL-17R signaling pathway to inhibit the onset and progression of related immune-inflammatory responses. Currently, the NDA for gumokimab in moderate-to-severe plaque psoriasis has been accepted by the NMPA, and a phase III clinical trial for ankylosing spondylitis is ongoing.

About Akeso

Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has created a unique integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the core, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode, and has gradually developed into a globally competitive biopharmaceutical company focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 22 candidates have entered clinical trials (including 11 bispecific/multispecific antibodies and bispecific antibody-drug conjugates). Additionally, 5 new drugs are commercially available, and 5 new drugs across 7 indications are currently under regulatory review for approval. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin, and X .

Agoda Highlights Global Events to Spark Wanderlust in 2025

SINGAPORE, Jan. 27, 2025 /PRNewswire/ — Digital travel platform Agoda shares a list of five global events in 2025 that are set to captivate travelers worldwide. These occasions provide opportunities to explore diverse cultures, witness natural wonders, and participate in significant gatherings, inviting travelers to broaden their horizons and create meaningful connections.

2025 promises a variety of unique sports, cultural, and celestial experiences for those eager to explore. These gatherings mix enjoyment and discovery, attracting travel enthusiasts from across the globe.

Andrew Smith, Senior Vice President, Supply at Agoda shared, “With some amazing events on the calendar, 2025 is shaping up to be an exciting year for travelers looking for a unique experience. With a wide range of accommodations, flights, and activities, all wrapped in a seamless booking experience, Agoda is here to help capture every moment by making travel planning both effortless and enjoyable.”

Here are five events special to 2025 to include on this year’s travel itinerary:

2025 Jubilee Year – Rome, Italy (Throughout 2025)

Celebrate the 2025 Jubilee in Rome, a special holy year observed once every 25 years. This event marks a time for reflection and pilgrimage, drawing millions to the Eternal City. A key highlight is the World Meeting of Families in June 2025, which will unite families from around the world for faith-focused events. Throughout the year, various special jubilees and celebrations offer unique opportunities for the more spiritual traveler.

Northern Lights – Tromsø, Norway (January – April)

Witness the awe-inspiring Northern Lights in Tromsø, Norway, a prime location for viewing this natural wonder. The aurora borealis is a yearly phenomenon, but 2025 is expected to be particularly remarkable due to the solar maximum, a period of increased solar activity, which enhances the likelihood of spectacular displays. This celestial event offers travelers a chance to see the sky illuminated in vivid colors, providing a unique opportunity to connect with nature.

World Expo 2025 – Osaka, Japan (April 13October 13)

Osaka hosts the World Expo, a six-month global display of innovation and culture. Visitors can explore diverse pavilions, experience advanced technologies, as well as enjoy Osaka’s and the Kansai region’s unique cultural offerings.

SAIL AmsterdamAmsterdam, Netherlands (August 20 – 24)

Experience the maritime spectacle of SAIL Amsterdam, a unique event that takes place every five years. The city will host an impressive fleet of tall ships, naval vessels, and historical boats from around the world. Visitors can enjoy ship tours, parades, and cultural performances along the IJhaven, offering a rare glimpse into maritime history and the lively atmosphere of Amsterdam’s waterfront.

SEA Games – Bangkok, Thailand (December 9 – 20)

The Southeast Asian Games, commonly known as the SEA Games, is a biennial multi-sport event involving participants from the region. In 2025, Bangkok will host athletes, competing in a variety of sports and showcasing exceptional talent and sportsmanship. This event offers a chance to experience the culture and camaraderie of Southeast Asia, with competitions held in various venues throughout the city.

With over 5 million holiday properties, more than 130,000 flight routes, and over 300,000 activities, Agoda offers travelers the flexibility to seamlessly plan their trips around these events. For more information on how to book your next adventure, visit agoda.com or download the Agoda app.

Best Travel Destinations to Go in 2025’s Year of the Snake, Based on Your Chinese Zodiac

SINGAPORE, Jan. 27, 2025 /PRNewswire/ — As the Year of the Snake approaches in 2025, it’s time to take a leaf from the wisdom of the snake and align your travel plans with the stars. Using the guidance of the Chinese Zodiac and consulted by Fengshui Masters from Way Feng Shui, Trip.com Group has curated personalised recommendations for every sign. For even more inspiration, we’ve also used Trip.com’s Trip.Best, an AI-curated list based on user reviews, to suggest top recommendations for stays and activities.


As more travellers look to astrology to decide their next trip, there’s no harm in getting some inspiration on the best destinations to explore, stays to book, and activities to enjoy based on your Zodiac animal’s unique tastes. Who knows…this might be your best trip itinerary yet.

Rat (鼠) – 1924, 1936, 1948, 1960, 1972, 1984, 1996, 2008, 2020

Recommended Directions: Southeast, Southwest
Destinations: Sydney, Australia; Queenstown, New Zealand

Always inquisitive, Rats adore places that combine the buzz of the city with the thrill of the outdoors. Whether it’s Sydney’s iconic landmarks or Queenstown’s jaw-dropping scenery, these destinations serve up the perfect balance of urban charm and natural wonder—just the right combo to satisfy a Rat’s restless curiosity.

Stays: Wake up to stunning lake views at BreakFree The Point in Queenstown or live luxe at Four Seasons Hotel Sydney.
Activities: Go whale-spotting on scenic cruises or get close to cute critters at Queensland’s charming Lone Pine Koala Sanctuary.

Ox (牛) – 1925, 1937, 1949, 1961, 1973, 1985, 1997, 2009, 2021

Recommended Directions: North, West
Destinations: London, U.K; Edinburgh, Scotland

Oxen like things steady and rooted, so they’re all about destinations with history and a bit of grandeur. London’s got the landmarks, the culture, and a dash of royal flair—perfect for the Ox who appreciates tradition. Edinburgh, with its castles and rugged charm, offers a mix of history and outdoor adventure that’ll keep an Ox entertained without breaking their stride.

Stays: An elegant option like The Cavendish London or the Dalhousie Castle Hotel, a 13th-century fortress set within wooded parkland.
Activities
: Delve into a bit of history at the royal Westminster Abbey in London or visit the iconic Edinburgh Castle.


Tiger (虎) – 1926, 1938, 1950, 1962, 1974, 1986, 1998, 2010, 2022

Recommended Directions: South, Northwest
Destinations
: Reykjavik, Iceland, Singapore

Tigers are bold, adventurous, and always ready for a challenge. Reykjavik caters to their love for the extraordinary, with dramatic landscapes and unique experiences that resonate with their fearless personality. Alternatively, Singapore offers a modern, vibrant metropolis with cutting-edge architecture, stunning nature reserves, and a mix of cultures which will give the big cat a roaring good time.

Stays: Hotel Borg in Reykjavik or the personality-filled The Scarlet Singapore.
Activities: Go on an adventurous glacier hike at Myrdalsjokull Glacier, Iceland, or soar above the cosmopolitan city with a ride on the Singapore Flyer.

Rabbit (兔) – 1927, 1939, 1951, 1963, 1975, 1987, 1999, 2011, 2023

Recommended Directions: Northeast, Northwest
Destinations
: Kyoto, Japan; Victoria, Canada

Rabbits are all about elegance and beauty, so they’re drawn to places that feel like living postcards. Kyoto’s serene temples and tranquil gardens offer the kind of calm that makes a Rabbit feel at peace, while Victoria, the “City of Gardens,” serves up colonial architecture, lush greenery, and harbour views—a dream for anyone who enjoys a little refinement.

Stays: Hoshinoya Kyoto for panoramic mountain views, or The Fairmont Empress in Victoria with harbour views.
Activities: Hop aboard the Arashiyama Sagano Romantic Train from Kyoto, or smell the flowers — literally — at Victoria and Butchart Gardens.

Dragon (龙) – 1928, 1940, 1952, 1964, 1976, 1988, 2000, 2012, 2024

Recommended Directions: North, Southwest
Destinations: Cape Town, South Africa; Cairo, Egypt

Dragons don’t do dull, and Cape Town and Cairo are anything but. Cape Town’s got dramatic mountains, city streets, and cosmopolitan energy to match a Dragon’s fiery spirit. Then there’s Cairo—where history literally sits in your face (hello, Pyramids!) while the city hums with modern vitality.

Stays: Boutique stays like The Silo Hotel in Cape Town or the Kempinski Nile Hotel in Cairo
Activities: Gaze upon epic landscapes on a cable car at Table Mountain, Cape Town or take to the water with a river cruise down the ancient River Nile.


Snake (蛇) – 1929, 1941, 1953, 1965, 1977, 1989, 2001, 2013, 2025

Recommended Directions: Southwest, West
Destinations: Maldives; Zurich, Switzerland

Snakes appreciate peace, luxury, and a touch of class—so Maldives and Zurich are practically made for them. The Maldives offers secluded beaches, spa treatments, and underwater wonders, for a truly special escape. Meanwhile, Zurich delivers lake views, refined dining, and a calm atmosphere perfect for some introspective relaxation.

Stays: Premium options like the Park Hyatt Maldives Hadahaa or The Dolder Grand in Zurich
Activities: Treat yourself to an overwater spa treatment in the Maldives or interact with ocean life while diving. Over in Zurich, tantalise your tastebuds with fine dining restaurants such as Igniv Zurich by Andreas Caminada or Widder Restaurant.

Horse (马) – 1930, 1942, 1954, 1966, 1978, 1990, 2002, 2014

Recommended Directions: Northeast, Northwest
Destinations: Chengdu, China; Seoul, Korea

For the Horse, travelling isn’t about lazy afternoons by the pool — it’s about nonstop action, and cramming as many experiences into each day as possible. Chengdu, China, is the perfect match, offering a heady mix of spicy hot pot, adorable pandas, and a cultural scene so rich, you’ll never want to slow down. Meanwhile, Seoul keeps the Horse on its toes with its blend of cutting-edge tech, busy shopping streets, and K-drama-worthy historic sites.

Stays: After a day of conquering the city, unwind at the sleek Chinese-style The Temple House, or go luxe at the Josun Palace Hotel in Gangnam.
Activities: Gaze upon adorable pandas at the Chengdu Research Base of Giant Panda Breeding or rack up social media points at the regal Gyeongbokgung Palace in Korea.

Goat (羊) – 1931, 1943, 1955, 1967, 1979, 1991, 2003, 2015

Recommended Directions: South 
Destinations
: Chiang Mai, Thailand: Ubud, Bali

Goats are the artists of the zodiac, drawn to beauty and inspiration in nature. Chiang Mai and Ubud, with their stunning landscapes, are the perfect backdrops for their creative souls. From lush mountains to verdant jungles, both destinations are a feast for the eyes and a canvas for the imagination.

Stays: Tranquil retreats like Anantara Chiang Mai Resort or picturesque villas set in a tropical rainforest like Four Seasons Resort Bali at Sayan Ubud.
Activities: Look in awe at the grand Doi Suthep temple in Chiangmai, or score beautiful photos on the Real Bali Swing.

Monkey (猴) – 1932, 1944, 1956, 1968, 1980, 1992, 2004, 2016

Recommended Directions: North, Southwest
Destinations: Dubai, UAE; Mongolia

Monkeys are all about mischief and adventure — they’re never far from the action. Whether it’s living it up in the ultra-glamorous playground of Dubai or swinging through the vast, wild expanses of Mongolia like a nomad, these destinations are the ultimate adrenaline hotspots for the Monkey.

Stays: Opulent choices like Jumeirah Burj Al Arab in Dubai, or sleeping under the stars at a luxurious yurt camp in the Gobi Desert.
Activities: Go on a desert safari adventure in Dubai’s dunes or with a Gobi Desert jeep tour in Mongolia. Else, give your spiritual side a workout too at the Gandan Monastery.

Rooster (鸡) – 1933, 1945, 1957, 1969, 1981, 1993, 2005, 2017

Recommended Directions: Southwest, Northwest
Destinations: Stockholm, Sweden; Marrakech, Morocco

The Rooster thrives on precision, and Stockholm is like a well-organised dream with its perfectly planned streets — every detail in its place. But if you’re feeling bold and ready to ruffle some feathers, Marrakech is your antidote. With its vibrant chaos, grand palaces, and lively squares, it’s the wild adventure to shake you out of your perfectly ordered nest.

Stays: Check into the refined Hotel Diplomat, or the charming Selman Marrakech which oozes Arabian flair.
Activities: Wander through Gamla Stan’s cobblestone streets, or explore the Vasa Museum’s meticulously preserved ship. Alternatively, marvel at the intricate details of Bahia Palace.


Dog (狗) – 1934, 1946, 1958, 1970, 1982, 1994, 2006, 2018

Recommended Directions: Northeast, South
Destinations: New York City, USA; Shanghai, China

For the Dog, loyalty and adventure go hand-in-hand. New York City is your trusty sidekick, where you are guaranteed cool experiences at every turn. Whether you’re strolling through Central Park or catching a Broadway show, the Big Apple never lets you down. Over in Shanghai, it’s all about a city that’s as ambitious and energetic as you are, with vibrant street scenes and a nightlife that never sleeps.

Stays: Make memories at the legendary  Chelsea Hotel in New York, or at the Fairmont Peace Hotel with live jazz shows that echo the city’s soul.
Activities: Catch a Broadway show in NYC such as The Lion King, visit the Metropolitan Museum of Art, or take a cruise along Huangpu River for iconic views.

Pro tip: International travellers transiting in Shanghai can sign up for a free layover tour to see the city’s highlights.

Pig (猪) – 1935, 1947, 1959, 1971, 1983, 1995, 2007, 2019

Recommended Directions: North, Northeast
Destinations: Tokyo, Japan; Hong Kong SAR

The Pig is a connoisseur of life’s finer pleasures: good food, cosy spaces, and plenty of fun. Whether it’s diving into Tokyo’s sleek luxury or soaking up the fast-paced energy of Hong Kong SAR, Pigs thrive in cities where indulgence is key, but so is having a little playful adventure along the way. Tokyo offers the ultimate blend of high-tech wonder and elegant tradition, while Hong Kong SAR delivers top-notch food (dim sum!) and a side of Disney magic — perfect for indulging both the inner kid and the gourmet within.

Stays: Stylish city hotels like The Tokyo Edition in Ginza or The Upper House in Hong Kong SAR.
Activities: See the best of interactive art at TeamLab Planets Tokyo or indulge your inner child (or adrenaline junkie) at Hong Kong Disneyland.

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ — CARiNG Pharmacy is thrilled to announce its back-to-back victory in securing the Gold award in the retail category at the 2024 Putra Aria Brand Awards. This recognition highlights the brand’s unwavering commitment to excellence in the retail sector. Established in 2022 by the Association of Accredited Advertising Agents Malaysia (4As), the Putra Aria Brand Awards celebrate brands that excel in branding. Supported by the Malaysian Advertisers Association (MAA), Media Specialists Association (MSA), and Malaysian Digital Association (MDA), these awards underscore the importance of consumer trust, further solidifying CARiNG Pharmacy’s position as a trusted name in healthcare retail.

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards
CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

Heartfelt Thanks to Our Community

This remarkable milestone would not have been possible without the steadfast trust and unwavering support of our customers and the Malaysian community. Your confidence in CARiNG Pharmacy’s mission inspires us to continuously innovate and raise the standard of healthcare retail. We thank you for being an integral part of our journey and success.

Reflecting on this achievement, Mr Chong Yeow Siang, Managing Director from CARiNG Pharmacy stated, “This award is a testament to the trust our customers place in us every day. It motivates us to work even harder to meet their expectations and deliver excellence in all that we do.”

Introducing the “Mom & Cutie” Initiative: CARiNG for Moms and Babies

In line with our commitment to evolving alongside our customers’ needs, CARiNG Pharmacy is proud to unveil its new business segment, “Mom & Cutie.” Designed to support mothers and their little ones, this initiative offers an extensive range of baby care products and wellness solutions tailored for moms. By addressing the unique needs of families, the “Mom & Cutie” segment reaffirms our dedication to holistic care and nurturing relationships with the communities we serve.

Looking Forward: Strengthening Our Promise of Excellence

As we celebrate this incredible achievement, CARiNG Pharmacy remains committed to its mission of providing unparalleled healthcare solutions while fostering lasting connections within the community. Guided by our values of trust, innovation, and excellence, we pledge to uphold the highest standards as we continue to deliver quality products and services that enrich lives.

For more information about CARiNG Pharmacy’s offerings, visit www.caring2u.com.

JustMarkets Launched a Lunar Contest with Fantastic Prizes


JAKARTA, INDONESIA – Media OutReach Newswire – 27 January 2025 – As the festive season of Lunar New Year approaches, JustMarkets invites traders in Indonesia and Malaysia to celebrate with exciting opportunities and incredible prizes. The promotion was created for traders to showcase their skills and aim for rewarding trading experiences — all in the atmosphere of traditions, healthy competitiveness, and trading achievements.

JustMarkets celebrates Lunar New Year
JustMarkets celebrates Lunar New Year

Participants have the chance to win generous awards by joining the campaign, subscribing to JustMarkets social media channels, and demonstrating their expertise. From top prizes to pleasant bonuses, the promotion offers opportunities for everyone to make this Lunar New Year truly memorable and rewarding.

Joining the campaign is simple, all you need is to:

  1. Follow at least one of the official social media pages on Instagram or Facebook.
  2. Use JustMarkets trading chart to predict the price of gold at a specific date — on 7 February Fortune Day — and add the comment with prediction.
  3. Share promo posts in your story.

Prizes include 200 USD promo code for the 1st place, 150 USD for the 2nd one, and 100 USD promo code for the winner of the 3d place. The awards will be sent directly to winners’ JustMarkets accounts, guaranteeing a smooth access to rewards. Full details, including participation rules and prize specifics, are available on JustMarkets official website and social media channels.

Celebrate the Lunar New Year with JustMarkets and take your trading journey to the next level! Join JustMarkets promotion today, show your trading proficiency, and win amazing prizes for your efforts!
Hashtag: #JustMarkets #LunarNewYear #Gold

The issuer is solely responsible for the content of this announcement.

About JustMarkets

JustMarkets is a globally recognized multi-asset broker providing reliable and transparent trading services since 2012. The company has earned over 50 industry awards, highlighting its excellence in the financial sector. JustMarkets offers a diverse array of trading instruments, including forex, stocks, commodities, indices, metals, energies, and cryptocurrencies, serving clients in over 160 countries.

Alpro Pharmacy and OMRON Healthcare Unite to Combat Fake BP Monitors

Free Blood Pressure Monitor Accuracy Check Nationwide

KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ — Hypertension, or high blood pressure, affects 3 in 10 Malaysians, making it a prevalent health concern in the country (National Health and Morbidity Survey, 2019). Of the 3, only 2 are aware of their condition, while the other remains undiagnosed, highlighting a critical gap in health awareness and screening. According to the National Health and Morbidity Survey 2023, more than half (or 52%) of the total people affected do not have their blood pressure under control.

This reflects a pressing issue not only in early detection but also in effective management. Compounding the problem is the presence of counterfeit or substandard blood pressure (BP) monitors in the consumer market, leading to inaccurate readings and improper self-management. Ensuring reliable monitoring and raising awareness among the public is essential to combating this silent epidemic in Malaysia.

(From left: Ph. Wong Wen Jun (Procurement Director of Alpro Pharmacy), Ph. Anson Tan (Category Manager of Alpro Pharmacy), Masanori Matsubara (Managing Director of Omron Healthcare Singapore), Andre Van Gils (Senior General Manager, Global Sales and Marketing Group HQ, OMRON Healthcare Co., Ltd.)
(From left: Ph. Wong Wen Jun (Procurement Director of Alpro Pharmacy), Ph. Anson Tan (Category Manager of Alpro Pharmacy), Masanori Matsubara (Managing Director of Omron Healthcare Singapore), Andre Van Gils (Senior General Manager, Global Sales and Marketing Group HQ, OMRON Healthcare Co., Ltd.)

In line with efforts to promote better hypertension management, Alpro Pharmacy, Malaysia’s largest community pharmacy chain, has entered into a strategic partnership with OMRON Healthcare, a global leader in blood pressure monitoring. This collaboration aims to provide Malaysians with access to accurate BP monitoring services and raise public awareness on the importance of reliable home blood pressure monitoring.

Ph. Lim En Ni, Chief Pharmacist & Engagement Director of Alpro Pharmacy, said, “To control hypertension effectively, having a blood pressure monitor at home is crucial, and the accuracy of the monitor plays a significant role in achieving better health outcomes. Through this partnership with OMRON, we are proud to offer free accuracy checks for BP monitors at our outlets nationwide, including Sabah and Sarawak, ensuring that our customers can rely on their devices for precise readings and informed healthcare decisions.”

This service is already available to the public, with Alpro and OMRON providing authorized BP meter accuracy checks to verify the reliability of BP monitors. Additionally, this initiative includes a research project aimed at understanding the benefits of home BP monitoring. The findings will be used to further educate the public and promote reliable monitoring as an essential preventive healthcare measure.

Andre Van Gils, Senior General Manager, Global Sales and Marketing Group HQ, OMRON Healthcare Co., Ltd., said, “We are delighted to collaborate with Alpro Pharmacy to enhance public awareness of accurate home BP monitoring. Accurate readings are essential for effective hypertension management, and we look forward to making reliable BP monitors and services more accessible to Malaysians. This is another step forward in realizing our ‘Going for Zero, Preventive Care for the Health of Society’ vision that aims to enhance cardiovascular health awareness and prevent incidents.”

Ph. Lim En Ni concluded, “At Alpro, our mission is to empower the community with better health knowledge and services. This initiative aligns with our tagline, Reassurance that brings Smile, and our vision to create a healthy and vibrant world. By promoting accurate home BP monitoring, we hope to reduce the risk of cardiovascular diseases and improve overall health outcomes in Malaysia.”

For more information, visit any Alpro Pharmacy outlet for a free BP monitor accuracy check, contact 019-750 0612, or visit our microsite at https://www.alpropharmacy.com/event_promotion/bpm-accuracy-check-is-essential-for-everyone-check-your-bp-monitor-at-least-once-every-6-months/.

About Alpro Pharmacy

With a humble beginning starting with a single pharmacy outlet in the small town of Port Dickson in 2002, Alpro Pharmacy is now a diversified community chain pharmacy that provides comprehensive primary healthcare solutions via over 300 outlets including Alpro Pharmacy, Alpro Clinic, Alpro Physio and Alpro Baby, both online and offline, nationwide. It is supported by a team of more than 650 healthcare professionals, ranging from doctors, pharmacists, nutritionists, dietitians to physiotherapists and many other healthcare professionals.

Serving more than 3 million families in Malaysia, Alpro Pharmacy is the first and only community pharmacy in the country to provide RM1 million product liability insurance to safeguard the supply of genuine medications. With over 500,000 prescriptions filled per year, Alpro Pharmacy is also the largest prescription pharmacy chain in Malaysia.

For more information, please visit https://www.alpropharmacy.com.

About OMRON Healthcare

Committed to advance health and empower people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment.

Aiming to realize its vision “Going for Zero, Preventive Care for the Health of Society”, the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients to reduce cerebro-cardiovascular events, aggravation of respiratory diseases and restrictions due to chronic pain.

With well over 350 million units sold globally*, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals**.  Throughout its history, OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions and provides products and services in over 130 countries***.

OMRON Healthcare Group is headquartered in Kyoto, Japan

To learn more, please visit:

https://www.omronhealthcare-ap.com/my/why-choose-omron

https://www.omronhealthcare-ap.com/my/category/8-blood-pressure-monitor

Global: https://healthcare.omron.com/

* Cumulative sales of home-use digital blood pressure monitors worldwide. (as of May 2023)

**1 Frost & Sullivan Survey, Blood pressure clinician perception tracker surveys. (November 25, 2019, and U.S. News Staff 2020, U.S. News & World Report, accessed June 9, 2020)

** 2 Kantar Health. Survey with cardiologists. (2019)

*** Number of the countries where OMRON products and/or services are available (as of March 2023)